FDA Inspection
Ajinomoto Althea, Inc.Ajinomoto Althea, Inc. – FDA Inspection, May 9, 2025
Record Details
This FDA Inspection record concerns Ajinomoto Althea, Inc., with an inspection on May 9, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 8b921446-33b9-481d-a50d-77a8e09d9df6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1266794
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ajinomoto Althea, Inc.
16| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 9, 2023 | Not classified | Los Angeles District Office | |
| January 16, 2023 | Not classified | Los Angeles District Office | |
| May 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2019 | NAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Ajinomoto Althea, Inc.
- FDA Inspection 1218719 - 2023-09-20
- FDA Inspection 1223371 - 2023-02-09
- FDA Inspection 1195170 - 2023-01-16
- FDA Inspection 1142663 - 2021-05-25
- FDA Inspection 1108335 - 2019-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.